CAR-T cell therapy provides long, treatment-free remissions for relapsed multiple myeloma, using genetically modified T cells from the patient. Clinical trials show significant remission rates, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback